Vir Biotechnology, Inc. (VIR)
8.505
+0.06
(+0.65%)
USD |
NASDAQ |
Jun 09, 16:00
8.21
-0.30
(-3.47%)
After-Hours: 17:46
Vir Biotechnology Total Assets (Quarterly) : 1.026B for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | 903.01M |
| Revolution Medicines, Inc. | 2.254B |
| Kymera Therapeutics, Inc. | 1.669B |
| Arrowhead Pharmaceuticals, Inc. | 2.268B |
| Oncolytics Biotech, Inc. | 8.161M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 212.82M |
| Shareholders Equity (Quarterly) | 812.76M |
| Debt to Equity Ratio | 0.1176 |
| Current Ratio | 7.110 |
| Net Debt Paydown Yield | 0.03% |